1. Home
  2. NEO vs KRP Comparison

NEO vs KRP Comparison

Compare NEO & KRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • KRP
  • Stock Information
  • Founded
  • NEO 2001
  • KRP 2013
  • Country
  • NEO United States
  • KRP United States
  • Employees
  • NEO N/A
  • KRP N/A
  • Industry
  • NEO Precision Instruments
  • KRP Oil & Gas Production
  • Sector
  • NEO Health Care
  • KRP Energy
  • Exchange
  • NEO Nasdaq
  • KRP Nasdaq
  • Market Cap
  • NEO 963.9M
  • KRP 1.1B
  • IPO Year
  • NEO 1999
  • KRP 2017
  • Fundamental
  • Price
  • NEO $5.10
  • KRP $14.91
  • Analyst Decision
  • NEO Buy
  • KRP Hold
  • Analyst Count
  • NEO 8
  • KRP 5
  • Target Price
  • NEO $12.14
  • KRP $17.40
  • AVG Volume (30 Days)
  • NEO 2.3M
  • KRP 397.3K
  • Earning Date
  • NEO 07-29-2025
  • KRP 08-07-2025
  • Dividend Yield
  • NEO N/A
  • KRP 11.49%
  • EPS Growth
  • NEO N/A
  • KRP N/A
  • EPS
  • NEO N/A
  • KRP 0.07
  • Revenue
  • NEO $689,189,000.00
  • KRP $312,876,555.00
  • Revenue This Year
  • NEO $13.83
  • KRP $10.65
  • Revenue Next Year
  • NEO $11.35
  • KRP $4.10
  • P/E Ratio
  • NEO N/A
  • KRP $206.18
  • Revenue Growth
  • NEO 9.70
  • KRP 3.03
  • 52 Week Low
  • NEO $4.81
  • KRP $10.98
  • 52 Week High
  • NEO $19.12
  • KRP $16.99
  • Technical
  • Relative Strength Index (RSI)
  • NEO 24.08
  • KRP 65.26
  • Support Level
  • NEO $4.81
  • KRP $14.03
  • Resistance Level
  • NEO $6.61
  • KRP $15.09
  • Average True Range (ATR)
  • NEO 0.37
  • KRP 0.24
  • MACD
  • NEO -0.15
  • KRP 0.06
  • Stochastic Oscillator
  • NEO 10.86
  • KRP 83.02

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About KRP Kimbell Royalty Partners Common Units Representing Limited Partner Interests

Kimbell Royalty Partners LP owns and acquires mineral and royalty interests in oil and natural gas properties throughout the United States. The company's basins and producing regions include areas of interest in the Permian Basin, Mid-Continent, Terryville/Cotton Valley/Haynesville, Appalachian Basin, Eagle Ford, Bakken/Williston Basin, and DJ Basin/Rockies/Niobrara. Its revenues are derived from royalty payments received from operators based on the sale of oil, natural gas and NGL production, as well as the sale of NGLs that are extracted from natural gas during processing.

Share on Social Networks: